Department of Surgery, Rush University Medical Center, Chicago, IL; Department of Surgery, Cantonal Hospital Winterthur, Zurich, Switzerland; Institute of Physiology, Center for Integrative Human Physiology, University of Zurich, Switzerland.
Department of Radiology, St. Eloi University Hospital, Montpellier, France.
Surgery. 2019 Mar;165(3):525-533. doi: 10.1016/j.surg.2018.09.001. Epub 2018 Oct 25.
Liver hypertrophy induced by partial portal vein occlusion (PVL) is accelerated by adding simultaneous parenchymal transection ("ALPPS procedure"). This preclinical experimental study in pigs tests the hypothesis that simultaneous ligation of portal and hepatic veins of the liver also accelerates regeneration by abrogation of porto-portal collaterals without need for operative transection.
A pig model of portal vein occlusion was compared with the novel model of simultaneous portal and hepatic vein occlusion, where major hepatic veins draining the portal vein-deprived lobe were identified with intraoperative ultrasonography and ligated using pledgeted transparenchymal sutures. Kinetic growth was compared, and the portal vein system was then studied after 7 days using epoxy casts of the portal circulation. Portal vein flow and portal pressure were measured, and Ki-67 staining was used to evaluate the proliferative response.
Pigs were randomly assigned to portal vein occlusion (n = 8) or simultaneous portal and hepatic vein occlusion (n = 6). Simultaneous portal and hepatic vein occlusion was well tolerated and led to mild cytolysis, with no necrosis in the outflow vein-deprived liver sectors. The portal vein-supplied sector increased by 90 ± 22% (mean ± standard deviation) after simultaneous portal and hepatic vein occlusion compared with 29 ± 18% after PVL (P < .001). Collaterals to the deportalized liver developed after 7 days in both procedures but were markedly reduced in simultaneous portal and hepatic vein occlusion. Ki-67 staining at 7 days was comparable.
This study in pigs found that simultaneous portal and hepatic vein occlusion led to rapid hypertrophy without necrosis of the deportalized liver. The findings suggest that the use of simultaneous portal and hepatic vein occlusion accelerates liver hypertrophy for extended liver resections and should be evaluated further.
部分门静脉结扎(PVL)诱导的肝肥大通过同时进行实质横断(“ALPPS 程序”)而加速。本项在猪中的临床前实验研究检验了这样一种假设,即同时结扎肝脏的门静脉和肝静脉也可以通过消除门-门侧支而无需手术横断来加速再生。
将门静脉结扎的猪模型与新的门静脉和肝静脉同时结扎模型进行比较,术中超声识别出主要引流门静脉缺血区的肝静脉,并使用带垫片的肝实质缝线结扎。比较了动力学生长情况,并在 7 天后使用门静脉循环的环氧铸型研究了门静脉系统。测量门静脉流量和门静脉压力,并使用 Ki-67 染色来评估增殖反应。
猪被随机分配到门静脉结扎(n = 8)或同时门静脉和肝静脉结扎(n = 6)组。同时门静脉和肝静脉结扎耐受良好,导致轻微的细胞溶解,流出静脉缺血区无坏死。与门静脉结扎后(PVL)的 29 ± 18%相比,同时门静脉和肝静脉结扎后的门静脉供应区增加了 90 ± 22%(平均值 ± 标准差)(P <.001)。两种手术均在 7 天后形成了向去门静脉化肝脏的侧支循环,但同时门静脉和肝静脉结扎后的侧支循环明显减少。Ki-67 染色在 7 天的结果相似。
本项在猪中的研究发现,同时门静脉和肝静脉结扎导致了去门静脉化肝脏无坏死的快速肥大。这些发现表明,同时门静脉和肝静脉结扎可加速肝肥大,从而进行更大范围的肝切除术,应进一步评估。